203 related articles for article (PubMed ID: 28202869)
1. Treatment of Vasodilator-resistant Mixed Connective Tissue Disease-associated Pulmonary Arterial Hypertension with Glucocorticoid and Cyclophosphamide.
Sugawara E; Kato M; Hisada R; Oku K; Bohgaki T; Horita T; Yasuda S; Atsumi T
Intern Med; 2017; 56(4):445-448. PubMed ID: 28202869
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.
Jais X; Launay D; Yaici A; Le Pavec J; Tchérakian C; Sitbon O; Simonneau G; Humbert M
Arthritis Rheum; 2008 Feb; 58(2):521-31. PubMed ID: 18240255
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Favorable Responses to Immunosuppressive Treatment in Pulmonary Arterial Hypertension Associated With Connective Tissue Disease.
Yasuoka H; Shirai Y; Tamura Y; Takeuchi T; Kuwana M
Circ J; 2018 Jan; 82(2):546-554. PubMed ID: 28904255
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension.
Sanchez O; Sitbon O; Jaïs X; Simonneau G; Humbert M
Chest; 2006 Jul; 130(1):182-9. PubMed ID: 16840400
[TBL] [Abstract][Full Text] [Related]
5. Diastolic function of the heart in mixed connective tissue disease.
Végh J; Hegedus I; Szegedi G; Zeher M; Bodolay E
Clin Rheumatol; 2007 Feb; 26(2):176-81. PubMed ID: 16865311
[TBL] [Abstract][Full Text] [Related]
6. Two patients with mixed connective tissue disease complicated by pulmonary arterial hypertension showing contrasting responses to pulmonary vasodilators.
Kusaka K; Nakano K; Iwata S; Kubo S; Nishida T; Tanaka Y
Mod Rheumatol Case Rep; 2020 Jul; 4(2):253-261. PubMed ID: 33087021
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.
Cansu DÜ; Korkmaz C
Clin Rheumatol; 2023 Oct; 42(10):2601-2610. PubMed ID: 36396789
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary arterial hypertension in systemic lupus erythematosus may benefit by addition of immunosuppression to vasodilator therapy: an observational study.
Kommireddy S; Bhyravavajhala S; Kurimeti K; Chennareddy S; Kanchinadham S; Rajendra Vara Prasad I; Rajasekhar L
Rheumatology (Oxford); 2015 Sep; 54(9):1673-9. PubMed ID: 25929760
[TBL] [Abstract][Full Text] [Related]
9. The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review.
Kato M; Kataoka H; Odani T; Fujieda Y; Otomo K; Oku K; Horita T; Yasuda S; Atsumi T; Ohira H; Tsujino I; Nishimura M; Koike T
Lupus; 2011 Oct; 20(10):1047-56. PubMed ID: 21676917
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary arterial hypertension in mixed connective tissue disease: successful treatment with Iloprost.
Végh J; Soós G; Csipõ I; Demeter N; Ben T; Dezsõ B; Zeher M; Dévényi K; Gaál J; Szegedi G; Bodolay E
Rheumatol Int; 2006 Jan; 26(3):264-9. PubMed ID: 16010558
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of immunosuppressants with bridge vasodilator therapy in severe lupus erythematosus-associated pulmonary arterial hypertension.
Sanges S; Savale L; Lamblin N; Rémy-Jardin M; Humbert M; Sobanski V
ESC Heart Fail; 2019 Dec; 6(6):1322-1325. PubMed ID: 31536678
[TBL] [Abstract][Full Text] [Related]
12. [Pulmonary arterial hypertension in connective tissue disease].
Cottin V
Rev Mal Respir; 2006 Sep; 23(4 Suppl):13S61-72. PubMed ID: 17057632
[TBL] [Abstract][Full Text] [Related]
13. Vanishing pulmonary hypertension in mixed connective tissue disease.
Lahaye IE; Rogiers PE; Nagler JM; Chappel R
Clin Rheumatol; 1999; 18(1):45-7. PubMed ID: 10088949
[TBL] [Abstract][Full Text] [Related]
14. A case of mixed connective tissue disease complicated by pulmonary hypertension and ascites after addition of pulmonary vasodilators.
Kusaka K; Nakano K; Fukuyo S; Miyazaki Y; Matsunaga S; Tanaka Y
Mod Rheumatol Case Rep; 2022 Jun; 6(2):203-208. PubMed ID: 35274731
[TBL] [Abstract][Full Text] [Related]
15. Recovery from pulmonary hypertension in an adolescent with mixed connective tissue disease.
Friedman DM; Mitnick HJ; Danilowicz D
Ann Rheum Dis; 1992 Aug; 51(8):1001-4. PubMed ID: 1417105
[TBL] [Abstract][Full Text] [Related]
16. Ten year survival of a patient with advanced pulmonary hypertension and mixed connective tissue disease treated with immunosuppressive therapy.
Dahl M; Chalmers A; Wade J; Calverley D; Munt B
J Rheumatol; 1992 Nov; 19(11):1807-9. PubMed ID: 1491407
[TBL] [Abstract][Full Text] [Related]
17. Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial.
Coghlan JG; Galiè N; Barberà JA; Frost AE; Ghofrani HA; Hoeper MM; Kuwana M; McLaughlin VV; Peacock AJ; Simonneau G; Vachiéry JL; Blair C; Gillies H; Miller KL; Harris JHN; Langley J; Rubin LJ;
Ann Rheum Dis; 2017 Jul; 76(7):1219-1227. PubMed ID: 28039187
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment.
Tanaka E; Harigai M; Tanaka M; Kawaguchi Y; Hara M; Kamatani N
J Rheumatol; 2002 Feb; 29(2):282-7. PubMed ID: 11838845
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment with immunosuppression, anticoagulation and vasodilator therapy of pulmonary hypertension in SLE associated with secondary antiphospholipid syndrome.
Tam LS; Li EK
Lupus; 1998; 7(7):495-7. PubMed ID: 9796854
[TBL] [Abstract][Full Text] [Related]
20. Renal crisis due to intimal hyperplasia in a patient with mixed connective tissue disease (MCTD) accompanied by pulmonary hypertension.
Yamaguchi T; Ohshima S; Tanaka T; Tsukada S; Matsushita M; Kohmo S; Kanzaki T; Saeki Y
Intern Med; 2001 Dec; 40(12):1250-3. PubMed ID: 11813854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
